The haploinsufficiency of Rras2 and the B cell phenotype suggest that the total amount of R-RAS2 is tightly regulated and therefore, overexpression of RRAS2 by two-fold, or more, in human CLL could be relevant for the human disease. The gene discussed is RRAS2; the disease is B-cell chronic lymphocytic leukemia.